Therapies

Novartis has announced positive findings from its the Phase 3 trial assessing the efficacy and safety of Beovu (brolucizumab) to...

Retina Australia has awarded a total of $160,000 in study grants to some of the biggest names in Australian retinal...

Glaukos has unveiled a new single-use surgical gonioscopy lens that is said to provide exceptional clarity with expanded views of...

Medicinal cannabis is often presented as an alternative treatment for glaucoma. Although there is evidence that cannabis lowers intraocular pressure,...

Professor Robyn Guymer has led an expert panel to update RANZCO’s Referral Pathway for Age-Related Macular Degeneration (AMD) Management, which...

The world’s largest childhood myopia education resource developed by Australian optometry couple Dr Kate and Dr Paul Gifford has formed...

Melbourne biopharmaceutical company Opthea has received an $8.5 million research and development (R&D) tax credit from the Australian tax authority...

A Victorian biopharmaceutical company has reported positive results from a Phase 1 study examining the safety of its biodegradable implant...

Bausch + Lomb has acquired an exclusive license for a novel myopia control contact lens developed by a Sydney ophthalmic...

Australian of the Year and ophthalmologist Dr James Muecke has endorsed a new campaign aimed at motivating Australians in their...